2m 2m 2m 2m 2m 2m 2m
ANIXA BIOSCINCS (ANIX)
NASDAQ
$2.85+$0.09 (+3.26%)
Price as of Sep 11, 2026 7:57 PM EDT- $93.9MMarket Cap
- -5.96%1-Year Change
- BiotechnologyIndustry
ANIXA BIOSCINCS (ANIX)
$2.85+$0.09 (+3.26%)
ANIX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.76 | ||
Change | +$0.010 (+0.36%) | ||
Open | $2.87 | ||
High | $2.88 | ||
Low | $2.72 | ||
Previous Close | $2.75 | ||
Volume | 389,372 | ||
30-Day Average Volume | 310,986 | ||
1-Week Change | -10.10% | ||
1-Month Change | -14.29% | ||
1-Year Change | -5.96% | ||
3-Year Change | -18.10% | ||
5-Year Change | -44.80% | ||
Fundamentals | |||
Shares Outstanding | 34.0M | ||
Total Assets | $15.1M | ||
Market Cap | $93.9M | ||
Enterprise Value | $92.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$2.6M | ||
Free Cash Flow | -$1.8M | ||
EBIT | -$2.6M | ||
EBITDA | -$2.6M | ||
Net Working Capital | $13.2M | ||
EPS | -$0.08 | ||
Enterprise Value/EBITDA | -35 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -35 | ||
PEG | 2 | ||
Price/Free Cash Flow | -53 | ||
Price/Operating Cash Flow | -53 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue